Clarksville, MD, United States of America

Jun O Liu

This inventor holds 34 USPTO granted patents and 15 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Johns Hopkins University, Massachusetts Institute of Technology, Texas A&M University System. Active years: 1999-2026.

USPTO Granted Patents = 34 (Patent Applications = 15)

% Patents Active = 88.2

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 225(Granted Patents)

Location History:

Cambridge, MA (US) (1999 - 2004)
Clarkesville, MD (US) (2015 - 2016)
Baltimore, MD (US) (2020 - 2023)
Clarksville, MD (US) (2007 - 2024)

Company Filing History:

29 out of 3,790

Johns Hopkins University

patents

4 out of 8,568

Massachusetts Institute of Technology

patents

3 out of 1,321

Texas A&M University System

patents

4. 1 out of 3,332

Chinese Academy of Sciences

patents

5. 1 out of 2

Rapafusyn Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662493 - Non-immunosuppressive FK506 analogs and use thereof (2026-06-23),

2. 12649980 - Three-dimensional surface for protein and small molecule microarrays (2026-06-09),

3. 12565518 - Hybrid cyclic libraries and screens thereof (2026-03-03),

4. 12545666 - Itraconazole analogs and use thereof (2026-02-10),

5. 12049521 - Hybrid cyclic libraries and screens thereof (2024-07-30),

6. 11878045 - Inducing cell death by hyperactivation of motility networks (2024-01-23),

7. 11708391 - Rapaglutins, novel inhibitors of GLUT and use thereof (2023-07-25),

8. 11555054 - Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof (2023-01-17),

9. 11458141 - Aryl hydrocarbon receptor (AhR) agonists for the prevention and treatment of inflammatory disorders (2022-10-04),

10. 11066416 - Rapafucin derivative compounds and methods of use thereof (2021-07-20),

11. 11028078 - Itraconazole analogs and use thereof (2021-06-08),

12. 10954273 - Hybrid cyclic libraries and screens thereof (2021-03-23),

13. 10869908 - Inducing cell death by hyperactivation of motility networks (2020-12-22),

14. 10774110 - Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof (2020-09-15),

15. 10695319 - Glucose conjugates of triptolide, analogs and uses thereof (2020-06-30),

Title: The Innovative Journey of Jun O Liu

Introduction: Jun O Liu is a renowned inventor based in Clarkesville, MD (US) known for his groundbreaking contributions to the field of biotechnology and pharmaceuticals.

Latest Patents: Jun O Liu holds several patents in the areas of drug discovery, molecular biology, and bioinformatics, showcasing his continuous commitment to innovation and research.

Career Highlights: With a distinguished career spanning over two decades, Jun O Liu has held key positions in leading research institutions and biotech companies, where he has spearheaded numerous projects that have led to significant advancements in the medical field.

Collaborations: Throughout his career, Jun O Liu has collaborated with top scientists, researchers, and pharmaceutical companies globally, fostering a culture of innovation and knowledge exchange that has resulted in the development of cutting-edge technologies and life-saving medications.

Conclusion: Jun O Liu's passion for innovation, coupled with his relentless pursuit of scientific excellence, has solidified his reputation as a visionary inventor whose work continues to impact the world of biotechnology and pharmaceuticals.